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Abstract
Background—Endoscopic oesophageal
changes are diagnostically helpful and
identify patients exposed to the risk of dis-
ease chronicity. However, there is a seri-
ous lack of agreement about how to
describe and classify the appearance of
reflux oesophagitis
Aims—To examine the reliability of crite-
ria that describe the circumferential ex-
tent of mucosal breaks and to evaluate the
functional and clinical correlates of pa-
tients with reflux disease whose oesoph-
agitis was graded according to the Los
Angeles system.
Methods—Forty six endoscopists from
diVerent countries used a detailed work-
sheet to evaluate endoscopic video record-
ings from 22 patients with the full range of
severity of reflux oesophagitis. In separate
studies, Los Angeles system gradings were
correlated with 24 hour oesophageal pH
monitoring (178 patients), and with clini-
cal trials of omeprazole treatment (277
patients).
Results—Evaluation of circumferential
extent of oesophagitis by the criterion of
whether mucosal breaks extended be-
tween the tops of mucosal folds, gave
acceptable agreement (mean ê value 0.4)
among observers. This approach is used
in the Los Angeles system. An alternative
approach of grouping the circumferential
extent of mucosal breaks as occupying
0–25%, 26–50%, 51–75%, 76–99%, or 100%
of the oesophageal circumference, gave
unacceptably high interobserver variation
(mean ê values 0–0.15) for all but the low-
est category of extent (mean ê value 0.4).
Severity of oesophageal acid exposure was
significantly (p<0.001) related to the se-
verity grade of oesophagitis. Preteatment
oesophagitis grades A–C were related to
heartburn severity (p<0.01), outcomes of
omeprazole (10 mg daily) treatment
(p<0.01), and the risk for symptom relapse
oV therapy over six months (p<0.05).
Conclusions—Results add further support
to previous studies for the clinical utility
of the Los Angeles system for endoscopic
grading of oesophagitis.
(Gut 1999;45:172–180)
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The endoscopic oesophageal changes caused
by reflux disease are not only helpful diagnosti-
cally, but also identify patients exposed to a
significant risk of disease chronicity.1–4 Further-
more, the severity of oesophagitis gives useful
guidance as to the likelihood of success of par-
ticular treatments.5
Unfortunately, there is a serious lack of
agreement about how to describe and classify
the appearances of reflux oesophagitis. There
are shortcomings in the many diVerent pub-
lished systems. For example, many of these
systems use ambiguous terminology that is
variably interpreted by diVerent endoscopists;
some systems suVer from illogicalities; and
many doctors grade appearances that are now
known to be unreliable for the diagnosis of
reflux oesophagitis, such as oedema, increased
vascularity, etc.6 7 It is probably these deficien-
cies that lead some endoscopists to use
“personal” systems. The lack of agreement
about how to describe the endoscopic appear-
ances of reflux oesophagitis arises from a defi-
ciency of critical evaluation of approaches to
endoscopic grading of oesophagitis. This ham-
pers both accurate communication about the
clinical status of individual patients and the
interpretation of data from clinical trials of the
treatment of the disease.8 Our international
working group on the endoscopic classification
of oesophagitis, which is supported by the
World Organisation of Gastroenterology
(OMGE), developed and proposed the Los
Angeles Classification System in 19946 and
reported its first evaluation of the criteria used.
The system was so named because it was
presented at the Los Angeles World Congress
of Gastroenterology. The working group has
continued to meet regularly in order to
evaluate the proposed Los Angeles classifi-
cation and as a result of these discussions has
agreed that the definitive version of the classifi-
cation should be as given in table 1. This
version has been revised slightly from the pre-
viously published proposal,6 in response to the
concern that it is sometimes diYcult to
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determine with confidence whether a mucosal
break is completely circumferential or not. The
change of grade D from fully circumferential to
involvement of more than 75% of the circum-
ference has required a matching modification
of the definition of grade C.
The criteria used by the Los Angeles classifi-
cation focus on the description of the extent of
visible mucosal breaks in the belief that this is
of greatest diagnostic and prognostic value. In
the previous study from this group,6 which
used video recording and endoscopic photo-
graphs, we found that endoscopists were able
to identify mucosal breaks confined to the tops
of mucosal folds, lesions that extended around
the entire oesophageal circumference, and
complications of oesophagitis such as stricture
and columnar lined oesophagus. However, our
original assessment of the utility of criteria for
the assessment of the radial extent of mucosal
breaks was inconclusive because of deficiences
in the design of the sheet used to score particu-
lar endoscopic features.6 This was a major
limitation, as definition of circumferential
extent was judged to be a key measure of
oesophagitis severity. As a result of this experi-
ence, the score sheet for assessing this variable
was developed substantially and the revised
version used in the further evaluations pre-
sented in this report.
A system that classifies the endoscopic
changes of reflux oesophagitis should not only
be unambiguous and simple to use, but should
also be shown to distinguish between clinically
relevant grades of severity of reflux disease.
Thus the grading should distinguish among
groups of patients with diVering responses to
treatment and with diVering severity of reflux,
as assessed by other measurements. These cor-
relates have been assessed for the Los Angeles
system for the first time in the present study.
The study had therefore two major aims: to
examine the reliability of criteria that describe
the circumferential extent of mucosal breaks;
and to evaluate the functional and clinical cor-
relates of patients with reflux disease whose
oesophagitis was graded according to the Los
Angeles system.
Methods
INTEROBSERVER AGREEMENT
Forty six endoscopists from diVerent countries
and continents (Europe, USA, Australia, and
Japan) participated. Both trainee endoscopists,
defined as those who had performed less than
500 upper gastrointestinal endoscopies, and
experts who had performed more than 3000
upper gastrointestinal endoscopies were invited
to take part. Of the participants, 25 were clas-
sified as experts and 15 as trainees. Information
about the level of experience was unavailable
for six contributors. As we were unable to
reveal any significant diVerences in outcome
between these groups, we present data re-
trieved when analysing the entire study group
in the Results section. Each participant re-
ceived a videotape which contained edited
recordings of endoscopic images from 22 cases,
each lasting approximately 30 seconds. The full
range of severity of reflux oesophagitis was
covered by the recordings. Endoscopists used a
detailed worksheet (shown in full in the
Appendix), which was a development of the
one used in previous studies. The sheet scored
the full range of findings relevant to the evalu-
ation of an oesophagitis classification system,
according to predefined criteria. The previ-
ously agreed definition of mucosal breaks, “an
area of slough or erythema with a discrete line
of demarcation from the adjacent more normal
lookingmucosa”was used.6 The original video-
tapes were acquired with Olympus video endo-
scopes and either a Super-VHS or NT video
recorder. The copies that were distributed were
made directly from these original recordings.
Five centres participated in producing original
video material.
The most widely used coeYcient of agree-
ment in clinical studies, the ê statistic,9 was
used in its original version in order to evaluate
the degree of agreement among observers. The
range of possible values for ê is from −1, which
indicates perfect disagreement, to +1, which is
reached with perfect agreement. Agreement by
chance alone gives a value of 0. Though far
from perfect, values as low as 0.4 are
considered to indicate acceptable agreement.
In the ê statistics used, p0 is the observed pro-
portion of agreement and pC is the expected
agreement by chance in the relevant contin-
gency table.
We analysed the data from the large number
of observers as a multiple of comparisons
between each pair of observers. That is, if 46
observers recorded the presence or absence of
a particular feature, ê statistics were calculated
for a total of [n × (n − 1)] comparisons. This
means that a theoretical number of 2070 ê
values have been computed for each item. Each
ê value measured the agreement between two
observers in the endoscopic videotape record-
ings in the 22 patients; ê values are given as
medians and interquartile ranges.
FUNCTIONAL AND CLINICAL CORRELATES
Study I—Oesophageal pH monitoring
These data are a part product of a study into
the use of omeprazole as a diagnostic test,
which has been reported in detail elsewhere.10
Patients were recruited into the study if they
had heartburn as the main symptom for at least
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Table 1 The Los Angeles classification of oesophagitis
Grade A One (or more) mucosal break no longer than 5 mm, that does not extend
between the tops of two mucosal folds
Grade B One (or more) mucosal break more than 5 mm long that does not extend
between the tops of two mucosal folds
Grade C One (or more) mucosal break that is continuous between the tops of two or
more mucosal folds but which involves less than 75% of the circumference
Grade D One (or more) mucosal break which involves at least 75% of the oesophageal
circumference
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six months, or if their major symptom was acid
regurgitation, abdominal pain, or discomfort in
association with heartburn. In total, 178
patients were entered into the study from 17
centres in Denmark, Norway, and Sweden.
The patients scored their reflux induced symp-
toms in a structured manner during the last
two days before enrolment into the study as
either mild, moderate, or severe. At endoscopy,
oesophagitis was graded according to the Los
Angeles classification. Before entry into the
therapeutic trial ambulatory 24 hour pH
monitoring was carried out with a monocrys-
talline, antimony electrode positioned 5 cm
above the oral margin of the lower oesophageal
sphincter, which was located by stationary
oesophageal manometry. During the pH study,
the patients were asked to act as normally as
possible in order to minimise any impact on
reflux patterns that could result from the proc-
ess of measurement.8
Study II—Clinical correlates
In the other clinical study, the major therapeu-
tic outcomes of which have been reported
elsewhere,11 patients with upper gastro-
intestinal discomfort were recruited from the
primary care setting. The patients were
screened for reflux symptoms by use of a
questionnaire,12 which had been developed for
the diagnosis of symptomatic reflux disease,
and which focuses especially on objective
recognition of heartburn, and on exacerbating
or relieving factors. Patients with a question-
naire score of 4 or more, aged 18–80 years,
were screened by endoscopy for enrolment into
the study, provided that they had been experi-
encing upper gastrointestinal symptoms for at
least three months with episodes occurring on
at least four days during the previous week. At
endoscopy, oesophagitis was graded according
to the Los Angeles classification (table 1). For
ethical reasons, patients found to have Los
Angeles grade D oesophagitis, columnar lined
oesophagus, or peptic strictures were excluded
from further involvement in the study. Com-
plete endoscopic and clinical data were avail-
able for 496 of the 538 patients randomised to
treatment (see below). Of these, the 277 who
had mucosal breaks were randomised to either
omeprazole 20 or 10 mg daily. Patients without
mucosal breaks were randomised to either
omeprazole 20 or 10 mg daily or to placebo.
Treatment was given for four weeks, under
double blind conditions, after which it was
stopped in those who had complete symptom
relief. Those with persistent symptoms at four
weeks were given open therapy with omepra-
zole 20 mg daily for another four weeks. All
patients in whom symptoms were relieved at
four or eight weeks entered a follow up period
without treatment for up to six months, exiting
the study if their symptoms relapsed according
to predefined criteria before that time. There
were 145 patients who had mucosal breaks at
their pretreatment endoscopy who entered this
phase of the study.
STATISTICS
The relation between acid reflux variables and
endoscopic grading of mucosal breaks was
assessed with a logistic regression analysis in
which the endoscopic grade was the dependent
variable. The relation between symptom sever-
ity and endoscopic grading was evaluated by
cross tabulation of the severity of heartburn
and endoscopic grading and then a simple cor-
relation analysis. A log rank test was applied to
the proportion of patients in clinical remission
during follow up with the pretreatment endo-
scopic grading as the dependent variable.13
Results
INTEROBSERVER AGREEMENT
There was no significant diVerence in the levels
of agreement on judgements described below
between experienced endoscopists and train-
ees, so the entire data set was pooled. The most
important aspect of the endoscopic video
sequence assessments was the reproducibility
of evaluation of the circumferential extent of
mucosal breaks as judged by the extension of
mucosal breaks across the tops of two or more
mucosal folds. Such mucosal breaks were
assessed with the ê value of 0.4 (0.22–0.51)
(fig 1).
When endoscopists were asked to evaluate
the proportion of the circumference involved
by mucosal breaks as 0–25%, 26–50%, 51–
75%, 76–99%, or 100%, only the most limited
extent (0–25%) was recorded with any level of
accuracy (ê = 0.4, range 0.22–0.52). In the
remaining groups, ê values equalled or were
close to 0. Another aspect of assessing the cir-
cumferential extent was the assessment of
whether one or more mucosal folds were
involved by the mucosal breaks. The examiners
again showed an acceptable agreement, scoring
a ê value of 0.4 in this judgement.
The score sheets also allowed assessment of
interobserver variation in the recognition of
other aspects of the endoscopic oesophageal
appearances already evaluated in our previous
study.6 Agreement on the presence or absence
of a mucosal break in a particular endoscopic
video sequence had a ê value of 0.4 (0.21–
0.58). The presence of multiple mucosal
breaks (two or more) was assessed with a simi-
lar level of accuracy (ê value 0.4 (0.25–0.54)).
Figure 1 ê values for interobserver agreement on the
presence and extent of mucosal breaks (median values and
interquartile ranges).
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The presence of a stricture was assessed with
a ê value of only 0.33 (0–0.46) but there were
only two cases of stricture among the 22 cases.
For the four cases of columnar metaplasia (all
histologically confined), recognition of tongues
that extended up the oesophagus had a ê value
of 0.38 (0.13–0.58) and estimates of the
circumferential extent of this metaplastic epi-
thelium had a ê value of 0.42 (0.10–0.65). The
investigators were specifically asked to assess
the number and depth of ulcers, as opposed to
mucosal breaks, with an ulcer being defined as
a mucosal break greater than 3 mm deep. Reli-
able judgement on the presence of an ulcer was
not achieved as this assessment had a ê value of
−0.01 and the corresponding ê value for the
assessment of the number of ulcers only
reached −0.02.
The presence and absence of “minimal
endoscopic changes” as listed in table 2 was
evaluated close to the oesophagogastric mu-
cosal junction; there was no agreement on the
presence or absence of these findings.
FUNCTIONAL AND CLINICAL CORRELATES
Oesophageal pH monitoring and symptom
assessments were completed in 178 patients as
a prelude to inclusion in the short term thera-
peutic trial with omeprazole (table 3). There
was a significant relation between the Los
Angeles classification grade and the 24 hour
oesophageal acid exposure values (p<0.01).
There was also a significant correlation
between pretreatment symptom severity and
endoscopic grading of mucosal breaks (fig 2).
Table 2 ê values for the assessments of minimal changes in the distal oesophagus and the
gastro-oesophageal junction
Endoscopic features ê value
Excessive reddening of the cardia 0.09 (0.00–0.29)
Erythema of the squamocolumnar junction 0 (−0.08–0.06)
Friability of the squamocolumnar junction 0.04 (0.00–0.25)
Blurring of the squamocolumnar junction 0.08 (0.00–0.22)
DiVuse erythema of the distal oesophagus 0.08 (0.00–0.28)
Patchy erythema of the distal oesophagus 0.00 (−0.07–0.09)
Increased vascularity of the distal oesophagus 0.00 (0.00–0.09)
Oedema or accentuation of the mucosal folds 0.00 (−0.02–0.15)
Median ê values are given, as well as the first and third quartile.
Table 3 Acid reflux parameters in relation to endoscopic
grading of mucosal breaks
Number of
patients
% time
pH <4
Number of
reflux episodes
Normal 40 6.7 (1.0) 59.5 (12.8)
Grade
A 50 9.3 (1.3) 106.9 (12.8)
B 50 13.7 (2.1) 138.3 (20.0)
C 9 11.7 (3.0) 135.8 (29.4)
D 10 19.1 (6.6) 163.0 (41.7)
C + D 19 15.6 (3.8) 150.1 (25.5)
Results expressed as mean (SEM).
Normal versus grade A, B, C, D, p=0.0007; normal + grade A
versus grade B, C, D, p=0.003; normal + A, B versus grade C,
D, p=0.01.
Figure 2 Symptom severity as related to endoscopic grading of mucosal breaks in study I (A) and study II (B).
Symptoms were assessed with focus on the severity of heartburn.
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Figure 3 The relation between pretreatment endoscopic
grading of mucosal breaks and healing of these mucosal
breaks after four weeks of omeprazole 10 or 20 mg daily.
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Figure 4 Percentage of patients in clinical remission
during six months, follow up after initial treatment with
omeprazole, which had healed the oesophagitis and
controlled symptoms. The symptom relapse curves are given
for each pretreatment endoscopic grade. Normal versus
grade A, p=0.04; normal versus grade A + B + C,
p=0.002; normal + grade A + B versus grade C, p=0.003.
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The severity of heartburn correlated signifi-
cantly with the pretreatment endoscopic grade
in both studies (study I: r=0.31, p<0.001;
study II: r=0.23, p<0.01).
After four weeks of treatment with omepra-
zole 10 mg daily, there was a gradation of
endoscopic healing rates from 77% of grade A
patients to only 20% in grade C patients (fig 3).
There was a gradation of healing rates with
omeprazole 20 mg, but this time only between
grades B and C.
Symptomatic relapse after initial short term
treatment occurred in 83% of the patients dur-
ing a six month follow up period. The
proportion of patients still in clinical remission
during these six months showed a significant
relation to the pretreatment Los Angeles
classification grade of mucosal breaks (fig 4).
Discussion
This report provides data which support the
approaches used by the Los Angeles classifi-
cation to categorise the extent of oesophagitis.
Of special interest was the evaluation of the
circumferential extent of the mucosal breaks.
The data were generated by a newly structured
worksheet and new endoscopic images better
directed to the aim of the assessment than the
one used previously.6 These results indicate
that endoscopists can score the joining of
mucosal breaks between the tops of two
mucosal folds with fair agreement, thus allow-
ing scoring of circumferential extent with this
method. Determination of radial extent with-
out reference to mucosal folds had very poor
levels of agreement. This report gives clinical
and physiological data, which support the
practical relevance of the Los Angeles classifi-
cation and also provide the definitive descrip-
tion of the finally agreed form of the Los Ange-
les classification.
The version of the Los Angeles system
described in the previous report of this group6
was a proposed system still under evaluation,
which has now been modified slightly from the
original description (table 1). If, in the future,
further data suggest that the Los Angeles
classification could be improved by some
evolution of the criteria, it is important that
even a minor modification should be given an
entirely diVerent name, in order to avoid any
ambiguity as to what criteria have been used.
This is an important lesson, which has not been
learnt from the Savary and Miller grading
system.14–17 The first version of this grading
system diVers substantially from the second,
yet it is rarely stated which version is being
used, either in clinical practice or even in pub-
lished clinical trials. If the version in use is
stated, the reader must be familiar with the
detail of each version.
The major aim of the assessments of the
endoscopic images presented in this report
was to evaluate further how reliably endo-
scopists could assess the circumferential ex-
tent of mucosal breaks by localising the peaks
of the mucosal folds. It was believed that the
findings of the assessment from our previous
study6 could have been influenced by technical
limitations of the assessment method. The
present study gives a more positive indication
that the peaks of the oesophageal mucosal
folds are useful endoscopic landmarks for
determination of extent. Another important
message, related to the clinical usefulness of
the system, was that no apparent diVerences
emerged between experienced endoscopists
and trainees. We would have liked to have
obtained a stronger ê value than 0.4 to support
our recommendation for use of the peaks of
the mucosal folds as a primary method for
determining radial extent. Determination of
radial extent is, however, a necessary judge-
ment for endoscopic classification of oesoph-
agitis, and the peaks of the mucosal folds
appear to be the best option on the basis of the
data obtained.
The quality of the stored images continued
to be a significant technical limitation. The
stored images did not fully emulate the
sensitivity of a live endoscopy done by an
observer orientated to the use of the peaks of
the mucosal folds as radial landmarks. Further-
more, despite our best eVorts, the resolution of
some of the endoscopic images was not
optimal. Image quality was also impaired by
the processes of image storage and copying.
The stored images sent out for evaluation did
not allow the observer to “explore” the
oesophagus in order to clarify appearances.
Such clarification should always include partial
deflation of the oesophagus to recognise the
position of the folds. Similar limitations with
the current methodology might explain the dif-
ferences in ê values between the present inves-
tigation and that performed by Bytzer et al.7
However, significant advances in the optical
resolution of video endoscopes, and in the cap-
ture, storage, and reproduction of video endo-
scopic images in digital form are currently
being introduced. We believe that these techni-
cal developments will largely overcome the
problems caused by suboptimal resolution of
images as currently used. Our working group
plans to use these developments for prepara-
tion of educational material, but judged that it
was inappropriate to delay formal introduction
and evaluation of the Los Angeles classification
system pending the results of a further
assessment done with technically better im-
ages. It needs, however, to be emphasised that
the intraobserver variability in these situations
also requires further validation.
Previously, no attempt has been made to
define the endoscopic appearances that should
be taken as indicative of erosion or ulceration.
We have described these collectively as “endo-
scopic mucosal breaks” for reasons given
previously.6 The definition, “an area of slough
or erythema with a discrete line of demarca-
tion from the adjacent, more normal looking
mucosa”, still requires interpretation by the
observer, but it is at least more specific than no
definition at all, which has been the case until
now. Currently, some members of the working
group are conducting a study which correlates
endoscopic mucosal breaks with the histology
of biopsies directed precisely to sample these
areas. The group will also consider other
measures that may aid the distinction of
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patches or tongues of mucosal columnar
metaplasia frommucosal breaks.Methods that
hold some promise for this include high
resolution video endoscopy and dye spraying
methods.18
Although the classification of the extent of
the mucosal break was the primary aim of our
group, we included a scoring of so called mini-
mal changes as well. ê values close to or below
0 were obtained for recognition of “minimal
changes”, in keeping with results from another
group.7 Again we have to realise the pivotal role
of technical quality of images in order to assess
these subtle mucosal appearances. At present,
we consider that current evidence indicates
that reliable recognition of “minimal changes”
is problematical and that the diagnostic signifi-
cance of these changes for reflux disease is
uncertain. Possibly, better image quality may
make these changes more reliable in the future.
Until “minimal changes” are shown to be of
diagnostic value, they probably should not be
recorded as present or absent, as to do so only
causes confusion.
The Los Angeles classification was devel-
oped with the intention to provide a clinically
relevant stratification of the severity of oesoph-
agitis. Despite the lack of validation of other
oesophagitis classification systems there is con-
siderable data indicating that these recognise
clinically relevant variations of the severity of
oesophagitis. This is the case for both oesopha-
geal pH monitoring data and response to
medical treatment.19–21 The oesophageal acid
exposure data included in the present study
support the clinical relevance of the Los Ange-
les classification with the possible exception of
the acid reflux values in grade C patients.
However, data were available from only nine
patients with this oesophagitis grade, a number
that is probably too small to draw a meaningful
conclusion, given the obvious variability of pH
monitoring acid exposure data.
Large prospective, randomised clinical trials
gave us the opportunity to evaluate further the
clinical relevance of the Los Angeles classifi-
cation. Previous studies, which have used
diVerent endoscopic classification systems to
correlate the severity of symptoms with endo-
scopic grade, have given negative results.22 33 In
the present study there was a significant corre-
lation between the severity of heartburn and
the Los Angeles grading. The clinical studies
also found an impressive gradation of endo-
scopic healing relating to the endoscopic grad-
ing, when omeprazole was given in a dose of 10
mg daily for four weeks. The large numbers of
patients involved and the statistically signifi-
cant diVerences are arguments for the clinical
relevance of the Los Angeles classification. On
the other hand, the size of the r values (r=0.23–
0.31) emphasises that factors other than endo-
scopic grading play a significant role in the
clinical manifestation of the disease. It is worth
noting that the data obtained show that the
classification of patients into grade A and B
seems to provide a clinically relevant subdivi-
sion. These patients represent the most numer-
ous groups of patients suVering from reflux
diseases, which have previously been grouped
somewhat ambiguously into one grade by the
Savary and Miller classification.14 Additional
information relevant to the significance of the
Los Angeles classification system was gained
from following patients after a successful
initial, short term, drug therapy. The sympto-
matic relapse curves separated patients, who
before treatment had an absence of oesopha-
geal mucosal breaks, from those with Los
Angeles grades A–C.
The findings presented in this and our previ-
ous report,6 represent the only rigorous assess-
ment of an endoscopic grading system for
reflux oesophagitis. The criteria used for the
Los Angeles classification have been developed
and agreed on by a truly international working
group. It is hoped that this classification will be
used widely and without ad hoc modification,
with resultant improvement in communication
about patient status for both clinical and
research purposes.
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Appendix
Endoscopic classification of reflux oesophagitis
Mucosal breaks
Institution Investigator, Inititals Date /
1.    Is there a mucosal break?
2.    How many folds are involved by mucosal breaks? 
If yes –
Patient no Country Expert:
Trainee:
Yes/No
Yes/No
Yes/No1a
How many breaks < 5 mm diameter?
Only one Yes/No
Yes/No
Yes/No
1b
Many (2 or more) 1c
Do all have overlying white/yellow membrane 1d
How many breaks > 5 mm diameter?
Only one Yes/No
Yes/No
Yes/No
1e
Yes/No2aOnly one fold
Many (2 or more) 1f
Do all have overlying white/yellow membrane 1g
/
Yes/No2bMore than one fold
Yes/No2c
Many folds (2 or
more with mucosal 
breaks continuous 
between the tops of 2
or more folds, but not
circumferential)
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Ulcers
Complications
Stricture
3.    What proportion of the circumference is affected by mucosal breaks?
Yes/No3a0–25% 
Yes/No3b26–50% 
or
or
or
Yes/No3c51–75% 
or
Yes/No3d76–99% 
100%
(circumferential) 
How many mucosal breaks are > 3 mm deep?
Yes/No3e
4.
Is there an ulcer?5.
Yes/No4aOnly one
Yes/No4b
Yes/No5a
Is there an oesophageal stricture?6. Yes/No6a
If yes:
Is the stricture narrower than the endoscope?
(i.e. does the endoscope fail to pass the stricture)
Yes/No6b
How many ulcers are present? Yes/No5b
Yes/No5c
Are the ulcers contiguous with more superficial breaks? Yes/No5d
Many (2+)
Only one
Many (2+)
Barrett's oesophagus/metaplasia
7.    Is there excessive reddening at the cardia? Yes/No7
8.    Is columnar metaplasia (Barrett's epithelium) present?
       If yes:
                does it form fingers
                        and/or islands?   
Yes/No8a
Yes/No8b
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Is it circumferential
      (> 3 cm extent)?
  (8a and 8b are NOT mutually exclusive)
Minor features suggestive of oesophagitis
9.    Is the distal oesophageal mucosa normal?
Overall summary of endoscopic features of oesophagitis
10.   Mark relevant features of oesophagitis on diagrams:
28
cm
28
24
A R P L
L
A
P
R
Yes/No8c
Yes/No9a
If it is not normal, is there;
— erythema in one segment at the squamocolumnar junction? 9b Yes/No
— blurring or indistinctness of the squamocolumnar junction? Yes/No9c
— friability of the squamocolumnar junction? Yes/No9d
— diffuse erythema in the distal oesophagus? 9e Yes/No
— patchy erythema in the distal oesophagus? Yes/No9f
— increased vascularity in the distal oesophagus? Yes/No9g
— oedema or accentuation of the mucosal folds? Yes/No9h
0
20
16
12
8
4
0
L
A
P
R
L
A
P
R
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